Quarterly report · Q3
3055.TEDINET S100SUQB
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥209.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥262.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥199.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥2.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥151.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥137.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥146.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥92.6bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥80.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥59.3bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥57.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥57.6bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.5bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥828m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥856m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥865m | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥835m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥808m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥82.9 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.9 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.41 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.94 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.72 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-12-31 | ¥1.6bn |
| Otherother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥44m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥1.5bn |
| Otherother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥516m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥10.1bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥10.1bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥113m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥369m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥794m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥48m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥49.0bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥48.6bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥401m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥911m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥217m |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥153.6bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥146.9bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥218.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥209.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.1bn |
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥1.9bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥46m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥819m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥10.2bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.2bn |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9m |
| jpcrp040300-q3r_E03003-000Dispensing Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥14m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥362m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥825m |
| jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥25m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥49.2bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥48.9bn |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥379m |
| jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E03003-000Nursing Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥295m |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥143.5bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥136.6bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.9bn |
| jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥209.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥199.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Investment securities | Prior1YearInstant | 15338000000 | JPY |
| Investment securities | CurrentQuarterInstant | 16597000000 | JPY |
| Long term accounts receivable ioa | Prior1YearInstant | 94000000 | JPY |
| Long term accounts receivable ioa | CurrentQuarterInstant | 82000000 | JPY |
| Long term loans receivable | Prior1YearInstant | 311000000 | JPY |
| Long term loans receivable | CurrentQuarterInstant | 247000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 347000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 263000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 0 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | － | JPY |
| Other ioa | Prior1YearInstant | 760000000 | JPY |
| Other ioa | CurrentQuarterInstant | 753000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -104000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -79000000 | JPY |
| Investments and other assets | Prior1YearInstant | 16748000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 17865000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 39631000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 42273000000 | JPY |
| Assets | Prior1YearInstant | 137937000000 | JPY |
| Assets | CurrentQuarterInstant | 151878000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 70915000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 83135000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 2505000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 2420000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 1000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 2000000 | JPY |
| Income taxes payable | Prior1YearInstant | 693000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 244000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 982000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 644000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 138000000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 89000000 | JPY |
| Other cl | Prior1YearInstant | 2347000000 | JPY |
| Other cl | CurrentQuarterInstant | 2518000000 | JPY |
| Current liabilities | Prior1YearInstant | 77584000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 89055000000 | JPY |
| Long term loans payable | Prior1YearInstant | 14000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 13000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 1457000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 2054000000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 120000000 | JPY |
| Deferred tax liabilities for land revaluation | CurrentQuarterInstant | 120000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 350000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 324000000 | JPY |
| Long term accounts payable other | Prior1YearInstant | 396000000 | JPY |
| Long term accounts payable other | CurrentQuarterInstant | 436000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 337000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 338000000 | JPY |
| Other ncl | Prior1YearInstant | 232000000 | JPY |
| Other ncl | CurrentQuarterInstant | 231000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |